关注
yossi cohen
yossi cohen
Insitute of Hematology, Laniado Hospital, Israel
在 laniado.org.il 的电子邮件经过验证
标题
引用次数
引用次数
年份
Kidney involvement and renal manifestations in non‐Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients
N Da'as, A Polliack, Y Cohen, G Amir, D Darmon, Y Kleinman, ...
European journal of haematology 67 (3), 158-164, 2001
2932001
Umbilical cord blood transplantation–how, when and for whom?
Y Cohen, A Nagler
Blood reviews 18 (3), 167-179, 2004
2042004
Assessment of a personalized approach to predicting postprandial glycemic responses to food among individuals without diabetes
H Mendes-Soares, T Raveh-Sadka, S Azulay, K Edens, Y Ben-Shlomo, ...
JAMA network open 2 (2), e188102-e188102, 2019
1802019
The proliferation arrest of primary tumor cells out-of-niche is associated with widespread downregulation of mitotic and transcriptional genes
Y Cohen, O Gutwein, O Garach-Jehoshua, A Bar-Haim, A Kornberg
Hematology 19 (5), 286-292, 2014
1192014
Multiple micro-predators controlling bacterial communities in the environment
J Johnke, Y Cohen, M de Leeuw, A Kushmaro, E Jurkevitch, ...
Current opinion in biotechnology 27, 185-190, 2014
1102014
Phage therapy treatment of the coral pathogen Vibrio coralliilyticus
Y Cohen, F Joseph Pollock, E Rosenberg, DG Bourne
Microbiologyopen 2 (1), 64-74, 2013
1002013
Hematopoietic stem-cell transplantation using umbilical-cord blood.
Y Cohen, A Nagler
Leukemia & lymphoma 44 (8), 2003
962003
Model of personalized postprandial glycemic response to food developed for an Israeli cohort predicts responses in Midwestern American individuals
H Mendes-Soares, T Raveh-Sadka, S Azulay, Y Ben-Shlomo, Y Cohen, ...
The American journal of clinical nutrition 110 (1), 63-75, 2019
902019
The nature of the β-peak in the loss modulus of amorphous solids
Y Cohen, S Karmakar, I Procaccia, K Samwer
Europhysics Letters 100 (3), 36003, 2012
692012
GPRC5D is a promising marker for monitoring the tumor load and to target multiple myeloma cells
Y Cohen, O Gutwein, O Garach-Jehoshua, A Bar-Haim, A Kornberg
Hematology 18 (6), 348-351, 2013
622013
Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis
Y Cohen, G Amir, N Da'as, S Gillis, D Rund, A Polliack
American journal of hematology 71 (1), 47-49, 2002
592002
The ecology of vegetation of Israel
Y Waisel, G Pollak, Y Cohen
Tel Aviv University, Tel Aviv, Israel (in Hebrew), 1978
561978
Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance
Y Cohen, P Solal-Céligny, A Polliack
Haematologica 88 (7), 811-823, 2003
542003
Cord blood biology and transplantation
Y Cohen, A Nagler
IMAJ-RAMAT GAN- 6 (1), 39-46, 2004
492004
An atlas of robust microbiome associations with phenotypic traits based on large-scale cohorts from two continents
D Rothschild, S Leviatan, A Hanemann, Y Cohen, O Weissbrod, E Segal
PLoS One 17 (3), e0265756, 2022
462022
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre …
MA Dimopoulos, PG Richardson, NJ Bahlis, S Grosicki, M Cavo, ...
The Lancet Haematology 9 (6), e403-e414, 2022
422022
Large‐cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine–rituximab‐containing regimens: natural history …
Y Cohen, N Da'as, D Libster, G Amir, A Berrebi, A Polliack
European journal of haematology 68 (2), 80-83, 2002
382002
Monotherapy with rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma
Y Cohen, A Polliack, O Zelig, A Goldfarb
Leukemia & lymphoma 42 (6), 1405-1408, 2001
372001
Optimization of 6LiF: ZnS (Ag) scintillator light yield using GEANT4
Y Yehuda-Zada, K Pritchard, JB Ziegler, C Cooksey, K Siebein, ...
Nuclear Instruments and Methods in Physics Research Section A: Accelerators …, 2018
352018
Translocation t (11; 14) in newly diagnosed patients with multiple myeloma: Is it always favorable?
M Leiba, A Duek, N Amariglio, A Avigdor, N Benyamini, I Hardan, ...
Genes, Chromosomes and Cancer 55 (9), 710-718, 2016
332016
系统目前无法执行此操作,请稍后再试。
文章 1–20